- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
7
2 new
Companies which are more than 50% undervalued based on analyst price target.
7 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHO New | NOK 56.20 | -1.9% | -6.0% | NOK 1.5b | NOK 84.50 | PE106.4x | E94.6% | 0% | ||
NYKD | NOK 2.36 | -3.3% | -87.3% | NOK 772.0m | NOK 10.63 | PS15.9x | E-2.2% | n/a | ||
NAVA | NOK 22.00 | -7.9% | -41.3% | NOK 388.6m | NOK 37.00 | PE301.2x | E42.9% | n/a | ||
LYTIX | NOK 5.54 | -3.5% | -14.8% | NOK 378.2m | NOK 14.00 | PS34x | S47.2% | n/a | ||
BGBIO | NOK 7.70 | -3.6% | -63.8% | NOK 301.0m | NOK 20.00 | PS577.7x | E-23.5% | n/a | ||
ONCIN New | NOK 2.20 | -12.0% | n/a | NOK 202.9m | NOK 3.50 | n/a | n/a | n/a | ||
CRNA | NOK 0.65 | -0.9% | -90.3% | NOK 52.9m | NOK 2.00 | PE5.6x | E61.2% | n/a |
Page 1 of 1